There have been plenty of legally actionable statements made by and about NNVC. The following has been allowed to stand in a very public venue for quite a while and it contains a couple of doozies...highlights mine:
Sector: Healthcare Industry: Biotechnology Full Time Employees: 17
NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. Its products pipeline includes HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis. The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of all types of Dengue viruses; and HIVCide that is an escape-resistant anti-HIV nanoviricide. In addition, it is also involved in research and development of other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.
-------------------------------------------- How many employees does NNVC really have? Isn't it closer to half a dozen? None of the listed drugs has been commercialized. I'll bet you remember when they used that term on the home page of the website and took it down when that fact was pointed out. The Company could defend those falsehoods as appearing in public statements that they don't control, but there is zero doubt that they are deceptive and that the origin of the language is in filings that the Company itself made with the SEC multiple times. The most recent filings are clear when they say "To date, the Company does not have any commercialized products" and there is little doubt that the false statements that still appear in the public could be corrected with a phone call...guess the company is either too busy to bother or is happy with the public access to those false statements.
The problem with "legally actionable" is that someone actually has to be willing to take the action and in spite of the fact that there have been numerous opportunities to do so (prior to last week) and the share price has been crumbling for years, no one was moved to act. It will be interesting to see if a stumble from today's heights will provide the necessary motivation.
News 
Market Data 
Discover 
